What is the elimination half-life of omalizumab?
•
4 min read
The average elimination half-life of omalizumab is approximately 26 days in patients with asthma and 24 days in patients with chronic spontaneous urticaria [1.2.1, 1.2.5]. This extended half-life allows for infrequent dosing, typically every two or four weeks [1.2.4].
